Hereditary long QT syndrome
Hereditary long QT syndrome (HLQTS) is rare (1 in 10 000) but accounts for 50% of sudden cardiac death (SCD) in infancy and childhood. It is usually autosomal dominant (autosomal recessive genes are associated with deafness), and occurs in different forms, termed LQT1, 2, 3, etc. (Fig. 39.1a). The mechanism of death is a long-QT associated torsade-de-pointes (TDP) type ventricular tachycardia degenerating into ventricular fibrillation. The pathophysiological basis is genetic prolongation of the action potential duration (APD) leading to early after depolarizations (EADs), which underlie TDP (see Fig. 38.2). Only 60% of patients have any TDP; however, 30–40% of patients die during their first TDP event, in others TDP episodes are self-terminating until the final non-self-terminating lethal one. Eightyfive per cent of TDP episodes relate to physical/emotional stress. The untreated life expectancy is substantially reduced. Treatment (betablockers ± implantable cardioverter defibrillator [ICD]) is fairly effective. The diagnosis can be extraordinarily easy or extremely difficult, in part as 5% of affected family members have normal QT intervals! A scoring system (Table 39.1) has been suggested. However, the key to diagnosis is to measure the QT interval accurately (Fig. 39.2) and to think of the diagnosis in syncope.
Acquired long QT syndromes
Acquired long QT syndromes are common and the complicating arrhythmias (TDP) is the same as in HLQTS, emphasizing the importance of QT interval measurement in all syncope, regardless of family history: